Does RISDIPLAM Cause Salivary hypersecretion? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Salivary hypersecretion have been filed in association with RISDIPLAM (EVRYSDI). This represents 0.2% of all adverse event reports for RISDIPLAM.
8
Reports of Salivary hypersecretion with RISDIPLAM
0.2%
of all RISDIPLAM reports
1
Deaths
2
Hospitalizations
How Dangerous Is Salivary hypersecretion From RISDIPLAM?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISDIPLAM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RISDIPLAM Cause?
No adverse event (324)
Diarrhoea (280)
Asthenia (209)
Pneumonia (182)
Death (165)
Pyrexia (152)
Fatigue (145)
Muscular weakness (125)
Vomiting (121)
Drug ineffective (115)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which RISDIPLAM Alternatives Have Lower Salivary hypersecretion Risk?
RISDIPLAM vs RISEDRONATE
RISDIPLAM vs RISEDRONIC ACID
RISDIPLAM vs RISPERDAL
RISDIPLAM vs RISPERDAL CONSTA
RISDIPLAM vs RISPERIDONE